{
    "SLC22A3": {
        "expression": [
            {
                "Organ": "Brain",
                "Source": "Nishimura",
                "Relative Expression": 0.00578
            },
            {
                "Organ": "Kidney*",
                "Source": "Nishimura",
                "Relative Expression": 0.0499
            },
            {
                "Organ": "Liver*",
                "Source": "Nishimura",
                "Relative Expression": 0.124
            },
            {
                "Organ": "Placenta*",
                "Source": "Nishimura",
                "Relative Expression": 0.146
            },
            {
                "Organ": "Small Intestine*",
                "Source": "Nishimura",
                "Relative Expression": 0.0256
            },
            {
                "Organ": "Liver*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 6.392
            },
            {
                "Organ": "Kidney*",
                "Source": "Mean across all PMT Samples",
                "Relative Expression": 2.184
            }
        ],
        "inhibitors": [
            {
                "Inhibitor": "3,4-methylenedioxymetamphetamine (MDMA)",
                "IC50 (μM)": null,
                "Ki (μM)": "73.6",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Amantadine",
                "IC50 (μM)": null,
                "Ki (μM)": ">1000",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Atropine",
                "IC50 (μM)": 466.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Inhibitor": "Clonidine",
                "IC50 (μM)": 110.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Inhibitor": "Clonidine",
                "IC50 (μM)": null,
                "Ki (μM)": "373",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Inhibitor": "Cocaine",
                "IC50 (μM)": null,
                "Ki (μM)": ">1000",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "D-Amphetamine",
                "IC50 (μM)": null,
                "Ki (μM)": "460",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Desipramine",
                "IC50 (μM)": null,
                "Ki (μM)": "14",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Inhibitor": "Diphenhydramine",
                "IC50 (μM)": 695.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Inhibitor": "Etilefrine",
                "IC50 (μM)": 4448.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Inhibitor": "Famotidine",
                "IC50 (μM)": 6.7,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "OCT3-expressing oocytes",
                "Reference": "Bourdet, 2005"
            },
            {
                "Inhibitor": "Furamidine",
                "IC50 (μM)": 20.4,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Ming, 2009"
            },
            {
                "Inhibitor": "Guanidine",
                "IC50 (μM)": null,
                "Ki (μM)": "6201",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Inhibitor": "Histamine",
                "IC50 (μM)": null,
                "Ki (μM)": "140",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Grundemann, 1999"
            },
            {
                "Inhibitor": "Imipramine",
                "IC50 (μM)": null,
                "Ki (μM)": "42",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Inhibitor": "Ketamine",
                "IC50 (μM)": null,
                "Ki (μM)": "225.7",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Memantine",
                "IC50 (μM)": null,
                "Ki (μM)": "236",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Metformin",
                "IC50 (μM)": 2332.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "OCT3-expressing oocytes",
                "Reference": "Bourdet, 2005"
            },
            {
                "Inhibitor": "Metformin",
                "IC50 (μM)": null,
                "Ki (μM)": "904",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Umehara, 2007"
            },
            {
                "Inhibitor": "MK-801",
                "IC50 (μM)": null,
                "Ki (μM)": "224",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Pentamidine",
                "IC50 (μM)": 14.8,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Ming, 2009"
            },
            {
                "Inhibitor": "Phencyclidine",
                "IC50 (μM)": null,
                "Ki (μM)": "333",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Inhibitor": "Phenformin",
                "IC50 (μM)": null,
                "Ki (μM)": "134",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Umehara, 2007"
            },
            {
                "Inhibitor": "Phenoxy-benzamine",
                "IC50 (μM)": 6.13,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT2",
                "Reference": "Hayer-Zillgen, 2002"
            },
            {
                "Inhibitor": "Prazosin",
                "IC50 (μM)": 12.6,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT2",
                "Reference": "Hayer-Zillgen, 2002"
            },
            {
                "Inhibitor": "Procainamide",
                "IC50 (μM)": null,
                "Ki (μM)": "738",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Inhibitor": "Quinidine",
                "IC50 (μM)": 18.3,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "OCT3-expressing oocytes",
                "Reference": "Bourdet, 2005"
            },
            {
                "Inhibitor": "Quinidine",
                "IC50 (μM)": 22.7,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Ming, 2009"
            },
            {
                "Inhibitor": "Quinine",
                "IC50 (μM)": 37.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Inhibitor": "Ranitidine",
                "IC50 (μM)": 290.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "OCT3-expressing oocytes",
                "Reference": "Bourdet, 2005"
            },
            {
                "Inhibitor": "Ranitidine",
                "IC50 (μM)": 372.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Inhibitor": "Tetraethylammonium",
                "IC50 (μM)": 1237.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "OCT3-expressing oocytes",
                "Reference": "Bourdet, 2005"
            },
            {
                "Inhibitor": "Tetraethylammonium",
                "IC50 (μM)": 1476.6,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "CHO-OCT3",
                "Reference": "Ming, 2009"
            },
            {
                "Inhibitor": "Tetraethylammonium",
                "IC50 (μM)": null,
                "Ki (μM)": "1372",
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Inhibitor": "YM-252124 (YM758 metabolite)",
                "IC50 (μM)": 63.4,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Umehara, 2009"
            },
            {
                "Inhibitor": "YM155",
                "IC50 (μM)": 108.0,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Minematsu, 2010"
            },
            {
                "Inhibitor": "YM758",
                "IC50 (μM)": 15.9,
                "Ki (μM)": null,
                "Substrate used": "N-methylpyridinium",
                "Cell System": "HEK293-OCT3",
                "Reference": "Umehara, 2009"
            }
        ],
        "substrates": [
            {
                "Substrate": "Epinephrine",
                "Km (μM)": 240,
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Substrate": "Etilefrine",
                "Km (μM)": 2800,
                "Cell System": "CHO-OCT3",
                "Reference": "Muller, 2005"
            },
            {
                "Substrate": "Histamine",
                "Km (μM)": 180,
                "Cell System": "HEK293-OCT3",
                "Reference": "Grundemann, 1999"
            },
            {
                "Substrate": "Histamine",
                "Km (μM)": 220,
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            },
            {
                "Substrate": "Metformin",
                "Km (μM)": 2260,
                "Cell System": "CHO-OCT3",
                "Reference": "Nies, 2009"
            },
            {
                "Substrate": "N-methylpyridinium",
                "Km (μM)": 47,
                "Cell System": "HRPE-OCT3",
                "Reference": "Wu, 2000"
            },
            {
                "Substrate": "Norepinephrine",
                "Km (μM)": 2630,
                "Cell System": "HEK293-OCT3",
                "Reference": "Amphoux, 2006"
            }
        ],
        "ddi": [
            {
                "DDI": "1",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cetirizine",
                "Affected Drug": "Pilsicainide",
                "AUC": "1.4",
                "Cmax": "NS",
                "CLR": "ND",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Tsuruoka, 2006",
                "More Details": "DDI 1"
            },
            {
                "DDI": "2",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Cephalexin",
                "AUC": "NS",
                "Cmax": "NS",
                "CLR": "0.8",
                "CL/F": "0.8",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "van, 1986",
                "More Details": "DDI 2"
            },
            {
                "DDI": "3",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Dofetilide",
                "AUC": "1.5",
                "Cmax": "1.3",
                "CLR": "0.7",
                "CL/F": "0.7",
                "t1/2": "1.3",
                "Effect on PD": "yes",
                "Reference": "Abel, 2000",
                "More Details": "DDI 3"
            },
            {
                "DDI": "4",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Metformin",
                "AUC": "1.5",
                "Cmax": "1.7",
                "CLR": "0.7",
                "CL/F": "ND",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Somogyi, 1987",
                "More Details": "DDI 4"
            },
            {
                "DDI": "5",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Pilsicainide",
                "AUC": "1.3",
                "Cmax": "NS",
                "CLR": "0.7",
                "CL/F": "0.7",
                "t1/2": "1.2",
                "Effect on PD": "ND",
                "Reference": "Shiga, 2000",
                "More Details": "DDI 5"
            },
            {
                "DDI": "6",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Pindolol (S-enantiomer)",
                "AUC": "1.4",
                "Cmax": "1.3",
                "CLR": "0.7",
                "CL/F": "ND",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Somogyi, 1992",
                "More Details": "DDI 6"
            },
            {
                "DDI": "7",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Procainamide",
                "AUC": "1.4",
                "Cmax": "NS",
                "CLR": "0.6",
                "CL/F": "ND",
                "t1/2": "1.3",
                "Effect on PD": "ND",
                "Reference": "Somogyi, 1983",
                "More Details": "DDI 7"
            },
            {
                "DDI": "8",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Ranitidine",
                "AUC": "1.3",
                "Cmax": "NS",
                "CLR": "0.7",
                "CL/F": "ND",
                "t1/2": "1.3",
                "Effect on PD": "ND",
                "Reference": "van, 1986",
                "More Details": "DDI 8"
            },
            {
                "DDI": "9",
                "Implicated Transporter": "OCTs/MATEs",
                "Interacting Drug": "Cimetidine",
                "Affected Drug": "Varenicline",
                "AUC": "1.3",
                "Cmax": "ND",
                "CLR": "0.8",
                "CL/F": "0.8",
                "t1/2": "ND",
                "Effect on PD": "ND",
                "Reference": "Feng, 2008",
                "More Details": "DDI 9"
            },
            {
                "DDI": "10",
                "Implicated Transporter": "OATs/OCTs",
                "Interacting Drug": "Cotrimoxazole (trimethoprim/sulfamethoxazole)",
                "Affected Drug": "Apricitabine",
                "AUC": "1.7",
                "Cmax": "1.3",
                "CLR": "0.6",
                "CL/F": "0.6",
                "t1/2": "1.4",
                "Effect on PD": "ND",
                "Reference": "Shiveley, 2008",
                "More Details": "DDI 10"
            },
            {
                "DDI": "11",
                "Implicated Transporter": "OATs/OCTs",
                "Interacting Drug": "Cotrimoxazole (trimethoprim/sulfamethoxazole)",
                "Affected Drug": "Zidovudine",
                "AUC": "NS",
                "Cmax": "ND",
                "CLR": "0.4",
                "CL/F": "NS",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Chatton, 1992",
                "More Details": "DDI 11"
            },
            {
                "DDI": "12",
                "Implicated Transporter": "OCTs",
                "Interacting Drug": "Trimethoprim",
                "Affected Drug": "Zidovudine",
                "AUC": "NS",
                "Cmax": "ND",
                "CLR": "0.5",
                "CL/F": "NS",
                "t1/2": "NS",
                "Effect on PD": "ND",
                "Reference": "Chatton, 1992",
                "More Details": "DDI 12"
            }
        ]
    }
}